Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Atripla Drug Market Overview, Competitive development, Analysis 2016

(PharmaNewsWire.Com, January 21, 2017 ) Publisher Drug Report, "Atripla- Drug Insights, 2016" highlights the Atripla marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Atripla covering the total sales estimation and also provides the Atripla sales performance during the historical period and forecast period to 2018. Publisher's Report also covers the detailed clinical assessment of Atripla, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, Publisher's Report provides the SWOT analysis for the Atripla.

For more information http://www.reportsweb.com/atripla-drug-insights-2016

Report Scope

-A review of the Atripla based on information derived from company and industry-specific sources
-Coverage of the Marketed data of the Atripla on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
-Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Atripla with location details
-Patent Expiry Timeline and Exclusivity Details
-Route of Synthesis of the API
-Global Forecasted Sales Figure to 2018
-Qualitative and quantitative assessment of market space
-SWOT Analysis

Reasons to buy

-Evaluate the marketing status and exclusivity details of Atripla to exploit opportunities for generic drug development opportunities.
-Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Atripla.
-API intelligence over Atripla and gaining primary intelligence over Active Ingredients manufacturers across the globe.
-Understanding the chemical route of synthesis of Atripla.
-Uncovering opportunities in the rapidly growing the US market
-Stay ahead of competition by understanding the changing competitive landscape
-Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
-Make more informed business decisions from insightful and in-depth analysis of the drug's performance
-Obtain sales forecast for currently marketed drug for to 2018


Request Sample Copy http://www.reportsweb.com/inquiry&RW000182627/sample .

Table of Contents

1. DelveInsight Report Introduction
2. Atripla Overview
2.1 Market Competition
2.3 Competitors in Development
3 Global Sales Assessment
3.1 Historical Sales of Atripla
3.2 Forecasted Sales of Atripla
4 Product Description
4.1 Mechanism of Action
4.2 Pharmacodynamic Properties
4.3 Pharmacokinetic Properties
5 Marketed Details
5.1 United States
5.2 Europe
6 Patent Information
6.1 Patent Numbers and Expiry Details
6.2 Patent and Exclusivity Expiry Assessment United States (US)
6.3 Patent Details
7 Route of Synthesis
8 Global API Manufacturers Assessment
8.1 The United States Drug Master File (US DMF)
8.2 The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China
8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India
9 Generic Players
10 The Pipeline Coverage
11 Clinical Trials Information
11.1 Clinical Trials by Zone
12 Company Profile
12.1 Company Summary
12.2 Company Financials
13 SWOT Analysis
14 References
15 Appendix
16 Methodology
17 Consulting Services
18 About DelveInsight
19 Contact Us
20 Disclaimer

Make an enquiry: http://www.reportsweb.com/inquiry&RW000182627/buying

ReportsWeb.com

Priya Sisodia

+1-646-491-9876

sales@reportsweb.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC